» Articles » PMID: 10202926

Oral Gene Delivery with Chitosan--DNA Nanoparticles Generates Immunologic Protection in a Murine Model of Peanut Allergy

Overview
Journal Nat Med
Date 1999 Apr 15
PMID 10202926
Citations 205
Authors
Affiliations
Soon will be listed here.
Abstract

Food allergy is a common and often fatal disease with no effective treatment. We describe here a new immunoprophylactic strategy using oral allergen-gene immunization to modulate peanut antigen-induced murine anaphylactic responses. Oral administration of DNA nanoparticles synthesized by complexing plasmid DNA with chitosan, a natural biocompatible polysaccharide, resulted in transduced gene expression in the intestinal epithelium. Mice receiving nanoparticles containing a dominant peanut allergen gene (pCMVArah2) produced secretory IgA and serum IgG2a. Compared with non-immunized mice or mice treated with 'naked' DNA, mice immunized with nanoparticles showed a substantial reduction in allergen-induced anaphylaxis associated with reduced levels of IgE, plasma histamine and vascular leakage. These results demonstrate that oral allergen-gene immunization with chitosan-DNA nanoparticles is effective in modulating murine anaphylactic responses, and indicate its prophylactic utility in treating food allergy.

Citing Articles

Chitosan-DNA nanoparticles: synthesis and optimization for long-term storage and effective delivery.

Raimbekova A, Kart U, Yerishova A, Elebessov T, Yegorov S, Pham T PeerJ. 2025; 13:e18750.

PMID: 39872028 PMC: 11771301. DOI: 10.7717/peerj.18750.


Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research.

Taha M, Abdelwahab S, Moni S, Farasani A, Aljahdali I, Oraibi B Hum Vaccin Immunother. 2024; 20(1):2427464.

PMID: 39539151 PMC: 11572201. DOI: 10.1080/21645515.2024.2427464.


RNA-Based Vaccines and Therapeutics Against Intracellular Pathogens.

Kola N, Patel D, Thakur A Methods Mol Biol. 2024; 2813:321-370.

PMID: 38888787 DOI: 10.1007/978-1-0716-3890-3_21.


Solubilization of chitosan in biologically relevant solvents by a low-temperature solvent-exchange method for developing biocompatible chitosan materials.

Li B, Qiu L, Zhang J, Liu S, Xu M, Wang J Int J Biol Macromol. 2023; 254(Pt 3):127950.

PMID: 37951431 PMC: 10843559. DOI: 10.1016/j.ijbiomac.2023.127950.


Modulation of immune response by nanoparticle-based immunotherapy against food allergens.

Krishna S, Farhana S, T P A, Hussain S, Viswanad V, Nasr M Front Immunol. 2023; 14:1229667.

PMID: 37744376 PMC: 10515284. DOI: 10.3389/fimmu.2023.1229667.